Navigation Links
New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
Date:10/16/2007

NUTLEY, N.J., Oct. 17 /PRNewswire/ -- Ten abstracts providing new analyses of data from six major Phase III renal anemia studies for MIRCERA(R) will be presented at the upcoming 40th Annual Meeting of the American Society of Nephrology (ASN) in San Francisco on November 2 - 5, 2007.

Among the highlights will be new analyses from maintenance studies, including MAXIMA, PROTOS, STRIATA and RUBRA, and correction studies, including ARCTOS and AMICUS.

Please note all information presented at the ASN annual meeting is embargoed for media release until one hour after the time of presentation.

Abstracts accepted for the ASN annual meeting include:

-- Once-monthly intravenous (IV) C.E.R.A. maintains stable hemoglobin (Hb)

in dialysis patients (pts), irrespective of age or gender. S. Fishbane

et al. (SU-PO779. November 4: 10:00 a.m. - 12:00 p.m. PST. Exhibit

Hall, Moscone Center)

-- Stable hemoglobin (Hb) levels are maintained with once-monthly C.E.R.A.

in dialysis patients (pts), irrespective of mode of vascular access. F.

Locatelli et al. (SU-PO822. November 4: 10:00 a.m. - 12:00 p.m. PST.

Exhibit Hall, Moscone Center)

-- Once-monthly C.E.R.A. maintains stable hemoglobin (Hb) in patients

(pts) with chronic kidney disease (CKD), irrespective of baseline iron

levels. A. Nissenson et al. (SU-PO819. November 4: 10:00 a.m. - 12:00

p.m. PST. Exhibit Hall, Moscone Center)

-- C.E.R.A. maintains stable hemoglobin (Hb) in chronic kidney disease

(CKD), regardless of albumin or dialysis adequacy (Kt/V). W. Sulowicz

et al. (Publication Only)

-- Effect of baseline hemoglobin (Hb) on Hb stability in patients (pts)

with chronic kidney disease (CKD) receiving once-monthly C.E.R.A. N.W.

Levin et al. (SU-PO817. November 4: 10:00 a.m. - 12:00 p.m. PST.

Exhibit Hall, Moscone Center)

-- Anemia correction wi
'/>"/>

SOURCE Roche
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release Tablets as Effective Treatment for Schizophrenia
2. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
3. Medivation Announces Presentation of New Subset Analyses From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
4. Data Analyses Outline Efficacy and Safety of Mircera for the Treatment of Renal Anemia Associated With Chronic Kidney Disease
5. Safety Analyses of Clinical Data for Bifeprunox in Patients with Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar to Placebo
6. Lipitor Significantly Lowered Hospitalization Costs for Patients with Heart Disease, Two New Analyses Show
7. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
8. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
9. AVEO Pharmaceuticals Novel Oncology Research Platform and Clinical Pipeline to Be Featured at AACR
10. Everest Data on Short- and Long-Term Use of Otsukas Investigational Novel Treatment, Tolvaptan, Published in Journal of the American Medical Association and Featured in ACCs Late Breaking Clinical Trials
11. West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... , Sept. 22, 2014  AbbVie (NYSE: ... several clinical studies evaluating potential new medicines in ... the upcoming 2014 European Society of Medical Oncology ... Madrid, Spain . Data being presented include ... safety and efficacy of veliparib (ABT-888), a poly ...
(Date:9/22/2014)... Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) announced today ... overview and update at the NewsMakers in the Biotech ... a.m. Eastern Time (8:30 a.m. Pacific Time), at the ... . A live audio webcast of ... section of Arena,s website at www.arenapharm.com . A ...
(Date:9/22/2014)... , September 22, 2014 ... "Cell Line Development Market by Product (Equipment, Media and ... Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, ... 2019", published by MarketsandMarkets, analyzes and studies the ... Browse 114 market data tables and ...
Breaking Medicine Technology:AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 2AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 3AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 4Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 2Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 3Cell Line Development Market Worth $3.96 Billion by 2019 2Cell Line Development Market Worth $3.96 Billion by 2019 3Cell Line Development Market Worth $3.96 Billion by 2019 4
... Dec. 7 Access Pharmaceuticals, Inc.,(OTC Bulletin ... demonstrated the,ability, using the company,s proprietary Cobalamin(TM) ... animal model of diabetes, through,its oral insulin ... based upon the body,s natural absorption of ...
... DENVER, Dec. 6 Some 5,000 COPD patients ... Antitrypsin Deficiency (Alpha-1) in,a study marking a major ... Association for Respiratory Care (AARC)., The principal ... the,Division of Pulmonary Medicine, National Jewish Medical and ...
Cached Medicine Technology:Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin 2Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin 3Alpha-1 Foundation, AARC Cooperate on Study to Test 5,000 COPD Patients for Alpha-1 2Alpha-1 Foundation, AARC Cooperate on Study to Test 5,000 COPD Patients for Alpha-1 3
(Date:9/22/2014)... 22, 2014) McMaster scientists have found that an ... of antibiotics. , Although dozens of antibiotics target ... a certain part of bacteria are created, and they ... , The discovery is important as there is growing ... cures for infections ineffective. The World Health Organization has ...
(Date:9/22/2014)... 2014 Quincy Bioscience, one of ... promotes National Self-Improvement Month this September. ... should have access to self-improvement resources, especially for ... demand for products that preserve health is growing ... For over six years, Quincy Bioscience has been ...
(Date:9/22/2014)... (HealthDay News) -- Scans of young children,s brains ... This finding could potentially allow doctors to identify ... on, preliminary research suggests. "Early identification and ... as well as most neurodevelopmental disorders," the study,s ... of child and adolescent psychiatry at University of ...
(Date:9/22/2014)... September 22, 2014 In a continued ... Jeep Dodge Ram is launching an awareness campaign inspired ... (#blindeggchallenge or #ffbBEC) aims to raise awareness and funds ... throwing an egg in the air and trying to ... others and if a nominee does not complete the ...
(Date:9/22/2014)... 22, 2014 The struggles that lie ... (LEP) patients has been well-documented—reportedly, language barriers between doctors ... to the emergency room and an increased likelihood for ... At Sanford Health, the largest medical facility in the ... LEP population necessitated the need for Video Remote ...
Breaking Medicine News(10 mins):Health News:Quincy Bioscience Promotes National Self-Improvement Month 2Health News:Can Brain Scans Help Predict Young Children's Reading Abilities? 2Health News:Blind Egg Challenge Raises Awareness for Foundation Fighting Blindness 2Health News:Healthcare Cost Savings Case Study:Stratus Video Interpreting Assists Sanford Health System in Accommodating Increasing LEP Population,Saves a Predicted $100,000 Per Year 2Health News:Healthcare Cost Savings Case Study:Stratus Video Interpreting Assists Sanford Health System in Accommodating Increasing LEP Population,Saves a Predicted $100,000 Per Year 3Health News:Healthcare Cost Savings Case Study:Stratus Video Interpreting Assists Sanford Health System in Accommodating Increasing LEP Population,Saves a Predicted $100,000 Per Year 4
... Corporation,s (Nasdaq: CRVL ) quarterly earnings release, CorVel will be conducting a ... 11:30 am Eastern Time. , , Event: ... Dan Starck, President and CEO, ... 11:30 am Eastern Time, Tuesday, February 3rd, ...
... success rate is much lower for those over 40 who want ... Women under 35 who undergo six cycles of in vitro fertilization ... new study found. , But for women over 40, the odds ... , "IVF is a mainstay of the treatment of infertility, and ...
... 14 ISP and IT partner Spiderhost ... initiative by Get Healthy Florida to get ... most comprehensive community-wide health project to date: a year-long ... awareness of blood pressure and cardiovascular risk.The project challenges ...
... 14 Congressman Chaka Fattah (D-PA) issues the ... the SCHIP children,s insurance program by a bipartisan vote of ... , "The effort to bring change to Washington ... children took a major stride today. I have joined with ...
... RIVER EDGE, N.J., Jan. 14 Nephros, Inc. ... company developing and marketing filtration products for therapeutic ... that it has received notice from the NYSE ... or "AMEX" or the "Exchange"), regarding AMEX,s intention ...
... still share outcome disparities in treatment of liver disease, study ... treatment for hepatitis C does not appear to help Hispanic ... non-Hispanic whites, a new study suggests. , This is second ... not to respond well to the therapy, consisting of pegylated ...
Cached Medicine News:Health News:CorVel Corporation Announces Earnings Release Webcast 2Health News:IVF Treatments Often Work for Women Under 35 2Health News:IVF Treatments Often Work for Women Under 35 3Health News:Spiderhost's Custom Programming Helps Central Floridians Get Healthy 2Health News:Nephros Receives Notice of Intention to Delist from AMEX 2Health News:Nephros Receives Notice of Intention to Delist from AMEX 3Health News:Nephros Receives Notice of Intention to Delist from AMEX 4Health News:Hispanics Respond Poorly to Standard Hepatitis C Therapy 2
The essence of fluorescence analysis is sensitivity. The high throughput optical system in the RF-5301PC employs a blazed holographic grating, photomultiplier and digital signal processing to provide...
... BTF-111 miniature arrayed detector ... spectrometer for ?uorescence applications ... excitation light source modules ... 2D ?uorescence measurement which ...
Inquire...
FlexStationII offers the highest level of flexibility in developing functional cellular assays and analyzing real time kinetic data....
Medicine Products: